# DECIEM | THE ABNORMAL BEAUTY COMPANY account plan

> DECIEM, parent of The Ordinary, is a Toronto beauty group inside Estée Lauder; The Ordinary is a Scaling Brand ($400m to under $1,000m).

## At a glance

DECIEM, The Abnormal Beauty Company, is the Toronto-based parent company of The Ordinary, and its Toronto lab and production facilities develop and produce The Ordinary products in-house. It is owned by The Estée Lauder Companies, whose reports list The Ordinary among its Scaling Brands (net sales of $400 million to under $1,000 million) and NIOD, Avestan and Loopha among its Developing Brands. Estée Lauder reported fiscal 2026 net sales of $15,049 million (year to June 30, 2026) and approximately 55,000 employees. The Ordinary is sold in the entry price tier and opened its first standalone Malaysian boutiques in 2025.

## Business units

- **The Ordinary** (Scaling Brand: net sales of $400 million to under $1,000 million): Ingredient-focused skin care at entry prices, with products stating key ingredients and concentrations. It is in Estée Lauder's "Scaling Brands" tier and drove skin care growth in fiscal 2026; its Multi-Peptide Serum for Hair Density also lifted Hair Care. The brand opened first Malaysian boutiques in Pavilion Kuala Lumpur and Mid Valley Megamall.
- **NIOD**: Listed by Estée Lauder among its Developing Brands (net sales under $400 million). The documents describe it only by that tier.
- **Avestan**: Listed by Estée Lauder among its Developing Brands (net sales under $400 million). The documents describe it only by that tier.
- **Loopha**: Listed by Estée Lauder among its Developing Brands (net sales under $400 million). The documents describe it only by that tier.

## Strategic priorities

- **Scale The Ordinary as a Scaling Brand**: Estée Lauder groups The Ordinary with Le Labo, Bobbi Brown Cosmetics and Aveda as Scaling Brands, and its first quarter call credits it with double-digit growth in skin care, in Mainland China prestige share gains and in Hair Care via its Multi-Peptide Serum for Hair Density.
- **Grow share at the entry of prestige**: Management said it is "gaining market share in M·A·C and The Ordinary", and wants to apply the M·A·C and The Ordinary playbook at the entry of prestige to other brands such as Bobbi Brown, Clinique and Estée Lauder.
- **Expand in Asia Pacific and Southeast Asia**: DECIEM's CEO said Malaysia felt like the natural next step after "the continued success of The Ordinary in the Asia Pacific region", with stores designed to offer tailored skincare education and support. In Mainland China The Ordinary led prestige share gains alongside TOM FORD, Le Labo and La Mer.
- **Keep launches science-led and slow to hype**: The brand only launches "when it's ready, effective and makes sense for our community", and chooses education first over entertainment content.
- **Build a 3-year innovation pipeline**: DECIEM's CEO said a 3-year plan for new product innovations is in development, kept flexible around ingredient efficacy, formulation stability and scientific advances.

## Latest results

In Estée Lauder's fiscal 2027 first quarter (three months to September 30, 2026), Skin Care net sales were $1,651 million, up 5%, and La Mer and The Ordinary together added approximately $97 million. The Ordinary grew from targeted expanded consumer reach and key campaigns, and in Hair Care from its Multi-Peptide Serum for Hair Density. On the call, skin care organic sales rose 4%, "primarily driven by double-digit growth from La Mer and The Ordinary". The Ordinary was also among the brands leading Estée Lauder's prestige share gains in Mainland China for the seventh consecutive quarter.

## Investments and deals

- **In-house Toronto lab and production**: The Ordinary products are conceptualised, developed and produced in DECIEM's Toronto lab and production facilities, which the CEO says gives the lab team freedom to explore new technologies and ingredients.
- **Standalone stores in Malaysia**: The Ordinary opened its first Malaysian boutiques in Pavilion Kuala Lumpur and Mid Valley Megamall, designed as experiences with skincare education.
- **Sustainability strategy**: DECIEM's CEO said the company is "actively building our sustainability strategy", acknowledging there is still much to be done.

## Challenges and risks

- **Tariffs**: Estée Lauder expects tariffs to hurt fiscal 2027 profitability and cash flows, which affects its brands including The Ordinary.
- **Hype and trust in beauty**: The CEO describes an industry where consumers are asking smarter questions and says "trust will continue to become the most valuable currency in beauty", so brands must keep up on transparency.
- **Keeping the ethos while expanding**: DECIEM enters new markets only when it can deliver the same values and customer experience, prioritising integrity over rapid growth, which can slow rollout.
- **Western market and duty-free headwinds at group level**: Estée Lauder's outlook names challenges in key Western markets, duty-free retailer changes at the Beijing and Shanghai airports and the Middle East conflict.

## What leadership says

> "We don't play in the 'exclusivity' space. We only launch a formula when it's ready, effective and makes sense for our community." — Nicola Kilner, Co-founder and CEO of DECIEM, Buro 24/7 Malaysia interview, 2025-09-11

> "We currently have a 3-year plan in development for new product innovations" — Nicola Kilner, Co-founder and CEO of DECIEM, The Peak Malaysia interview, 2025-12-06

> "we are gaining in Skin Care in volume and in value" — Stéphane de La Faverie, President and CEO, The Estée Lauder Companies, Estée Lauder fiscal 2027 first quarter earnings call, 2026-11-02


## Where a supplier can help

- **Retail and education tooling for new stores**: The Ordinary's Malaysian boutiques are built as experiences with tailored skincare education; suppliers of in-store consultation, training or store technology can tie to the standalone-store roll-out.
- **Formulation, stability and ingredient testing**: With in-house development in Toronto and a 3-year innovation plan flexible around ingredient efficacy and formulation stability, ingredient, testing and lab-equipment suppliers have a fit.
- **Sustainability data and packaging**: DECIEM says it is building its sustainability strategy, so suppliers of footprint measurement and sustainable packaging could help define actions.
- **Consumer-reach and campaign analytics**: The Ordinary's growth came from targeted expanded consumer reach and key campaigns, which is relevant to media, social commerce and consumer-insight providers.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Form 10-K for the fiscal year ended June 30, 2026](https://www.sec.gov/Archives/edgar/data/1001250/000100125026000041/el-20260630.htm)

Annual report · 2026-08-19

- The Estée Lauder Companies Inc., founded in 1946, makes and sells skin care, makeup, fragrance and hair care through over 20 luxury and prestige brands in approximately 150 countries and territories.
- Fiscal 2026 (year to June 30, 2026): net sales $15,049 million (up 5% reported, 3% in constant currency), gross margin 75.5%, operating income $780 million, net earnings $182 million, diluted EPS $.50.
- Skin Care is the largest category at $7,338 million of net sales, then Makeup $4,276 million, Fragrance $2,779 million (up 12%) and Hair Care $565 million.
- Regions: The Americas $4,463 million, EUKEM $3,794 million, Asia/Pacific $3,746 million, Mainland China $3,058 million (up 12%); all four grew.
- Strategy "Beauty Reimagined" (since February 2025) plus the Profit Recovery and Growth Plan (PRGP): restructuring approvals concluded June 30, 2026, a net reduction of approximately 10,000 positions, charges of $1,748 million, annual target gross benefits of approximately $1,200 million.
- Approximately 55,000 employees at June 30, 2026, of which approximately 35,000 are demonstrators at points of sale; the Lauder family holds approximately 82% of the voting power.
- Risks named: tariffs (expected to hurt fiscal 2027 profitability and cash flows), weak Western markets, Asia travel retail duty-free changes, Middle East conflict, impairment exposure on Dr.Jart+, Too Faced and TOM FORD trademarks.
- Operating cash flow $1,773 million; capital expenditures $457 million; debt rated A- (negative outlook) by Standard & Poor's and A3 (negative outlook) by Moody's.

### [Form 10-Q for the quarter ended September 30, 2026 (fiscal 2027 first quarter)](https://www.sec.gov/Archives/edgar/data/1001250/000100125026000060/el-20260930.htm)

Interim report · 2026-11-02

- Fiscal 2027 first quarter (three months to September 30, 2026): net sales $3,715 million against $3,481 million, up 7% reported and 6% in constant currency.
- Gross margin 75.7% against 73.4%; operating income $408 million against $169 million; net earnings $233 million against $47 million.
- Diluted EPS $.64 as reported against $.13; as adjusted $.72 against $.32.
- Fragrance net sales $861 million, up 19%; Skin Care $1,651 million, up 5%; Makeup $1,048 million, up 2%; Hair Care $128 million, down 1%.
- All regions grew: Mainland China $614 million (up 15%), Asia/Pacific $952 million (up 9%), The Americas $1,227 million (up 5%), EUKEM $923 million (up 2%).
- Hair Care fell on Aveda supply chain logistical challenges; Too Faced and Bobbi Brown Cosmetics lowered Makeup growth.
- Cash and cash equivalents were $3,198 million at September 30, 2026 against $3,498 million at June 30, 2026.
- Outlook language unchanged: tariffs expected to hurt fiscal 2027 profitability and cash flows, Western market challenges, Beijing and Shanghai duty-free changes, Middle East conflict.

### [Deciem's CEO Nicola Kilner on The Ordinary's Extraordinary Rise, Transparency in Beauty, and Going Global (Buro 24/7 Malaysia)](https://www.buro247.my/beauty/skincare/nicola-kilner-the-ordinary-interview.html)

Executive talk · Nicola Kilner, Co-founder and CEO of DECIEM · 2025-09-11

- Nicola Kilner is introduced as co-founder and CEO of Deciem, "the parent company behind The Ordinary"; the brand was first launched in 2015 with founder Brandon Truaxe, and launched in Malaysia the month before the interview.
- The Ordinary's premise: make "commodity ingredients" such as vitamin C, niacinamide and hyaluronic acid "equally accessible to consumers" and state their concentration, with pharmaceutics (paracetamol) as the inspiration.
- Stated positioning: "We don't play in the 'exclusivity' space. We only launch a formula when it's ready, effective and makes sense for our community. Hype is never our driver—truth is."
- Expansion approach: a "purposeful approach", "prioritising transparency, education and brand integrity over rapid growth"; new markets are entered "only when we can deliver the same values and customer experience that define us globally".
- Southeast Asia: after "the continued success of The Ordinary in the Asia Pacific region", Malaysia was the "natural next step"; the new Kuala Lumpur stores are designed "to be experiences" with "tailored skincare education and support".
- Product direction: "continuously provide innovative and targeted skin care solutions at fair prices", with continued focus on research and development.
- Leadership: her style moved "from being hands-on with every detail to now focusing on empowering others and nurturing a strong, values-led culture".
- View of the market: consumers "are asking smarter questions", and "trust will continue to become the most valuable currency in beauty".

### [Nicola Kilner On The Future Of DECIEM & The Ordinary (The Peak Malaysia)](https://thepeak.com.my/people/nicola-kilner-on-the-future-of-deciem-the-ordinary/)

Executive talk · Nicola Kilner, Co-founder and CEO of DECIEM · 2025-12-06

- The Peak describes Nicola Kilner as "co-founder and CEO of DECIEM – the parent company of The Ordinary"; the interview coincides with The Ordinary opening its first Malaysian boutiques in Pavilion Kuala Lumpur and Mid Valley Megamall.
- Launch story: "We first launched eight products on our website in the UK and everything sold out within 12 hours."
- Global retailers shown the concept told the team to rename the products and change the packaging; "Because we had other brands, we had more confidence in The Ordinary. So we thought: let's just follow our gut."
- She argues that "consumer research is the worst thing a brand can do", because what consumers say they want differs from what they buy once it is launched.
- Product development is in-house: The Ordinary products are conceptualised, developed and produced "in our Toronto Lab and production facilities".
- Pipeline: "We currently have a 3-year plan in development for new product innovations", kept flexible around ingredient efficacy, formulation stability and scientific advances.
- Sustainability: the company is "actively building our sustainability strategy", acknowledging "there's still much to be done".
- Culture: values are carried by pillars (Scientific Pillar, People team) and a paid "Doing Good day" for volunteering.

### [Estée Lauder Companies fiscal 2027 first quarter earnings call: passages on The Ordinary (transcript)](https://www.fool.com/earnings/call-transcripts/2026/11/02/estee-lauder-el-q1-2027-earnings-call-transcript/)

Executive talk · Stéphane de La Faverie, President and CEO, The Estée Lauder Companies · 2026-11-02

- The call is The Estée Lauder Companies' fiscal 2027 first quarter call (2 November 2026); The Ordinary is cited repeatedly as a growth driver.
- Skin care organic sales grew 4%, "primarily driven by double-digit growth from La Mer and The Ordinary".
- Mainland China delivered 9% organic sales growth; ELC "outperformed the industry to gain prestige beauty share for the seventh consecutive quarter, led by TOM FORD, The Ordinary, Le Labo and La Mer".
- The Ordinary is described as being "in the entry price tier" and as "our latest addition in the market", "a resounding success", now "lapping the 1-year anniversary with very strong performance" in China.
- Share: "we are gaining market share in M·A·C and The Ordinary"; on The Ordinary, "we are gaining in Skin Care in volume and in value".
- Management wants to use the M·A·C and The Ordinary "playbook" at the entry of prestige for other brands such as Bobbi Brown, Clinique and Estée Lauder.
- Portfolio logic: "we are leveraging the whole portfolio, starting from Ordinary to La Mer and TOM FORD to reach consumers at every price point across brands".

## Questions about DECIEM | THE ABNORMAL BEAUTY COMPANY

### What is DECIEM?

DECIEM, The Abnormal Beauty Company, is a Toronto-based beauty group and the parent of The Ordinary, and it also has NIOD, Avestan and Loopha. It is owned by The Estée Lauder Companies.

### How big is The Ordinary?

Estée Lauder places The Ordinary in its Scaling Brands tier, with net sales of $400 million to under $1,000 million. Its CEO said in fiscal 2026 it posted double-digit organic sales growth.

### Who leads DECIEM?

Nicola Kilner is described as co-founder and CEO of DECIEM in 2025 interviews. The Ordinary was co-founded with Brandon Truaxe.

### What is The Ordinary's strategy?

It offers science-led, ingredient-focused skin care at fair prices, launches only when a formula is ready, and expands market by market, with Malaysia the latest. Estée Lauder also uses its playbook at the entry of prestige.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)_
